Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. All India Institute Of Medical Sciences (AIIMS) - Raipur

Verified

Basic Information

Site Overview

Source: Human-provided.

All India Institute of Medical Sciences Raipur is a premier government tertiary-care teaching hospital and research institute established in 2012 under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) to address regional disparities in advanced healthcare access in central India. Located in Raipur, Chhattisgarh, the institute operates as an autonomous body under the Ministry of Health and Family Welfare and offers comprehensive multi-specialty and super-specialty services across more than 40 clinical departments, supported by over 1500 hospital beds, advanced diagnostic facilities (including 3T MRI, CT, PET imaging), and dedicated emergency and trauma care units. With a strong emphasis on integrated patient care, medical education (MBBS, MD/MS, PhD, and nursing programs), and translational research, AIIMS Raipur handles a high patient load annually and is equipped with modern infrastructure such as ICUs, specialty clinics, and research laboratories, positioning it as a key…

Source: Trial-derived.
9Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
6Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
10Unique Conditions
Source: Trial-derived.
11Unique Sponsors

Conditions

Source: Trial-derived. Sickle Cell Disease (4)Source: Trial-derived. Cardiovascular Disease (1)Source: Trial-derived. Chronic Kidney Diseases (1)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Dialysis-dependent Kidney Failure (1)Source: Trial-derived. Hypovolemic Shock (1)Source: Trial-derived. Immunoglobulin A Nephropathy (IgAN) (1)Source: Trial-derived. Non-muscle Invasive Bladder Cancer (1)

Sponsors

Source: Trial-derived. Novo Nordisk A/S (3)Source: Trial-derived. The George Institute (2)Source: Trial-derived. Bayer (1)Source: Trial-derived. Biogen (1)Source: Trial-derived. Central Hospital, Nancy, France (1)Source: Trial-derived. Emerald Clinical Inc. (1)Source: Trial-derived. Forma Therapeutics, Inc. (1)Source: Trial-derived. ImmunityBio, Inc. (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Six-minute walk test

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot